ADDvise Group AB A (ADDV-A) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ADDvise Group AB A (ADDV-A) has a cash flow conversion efficiency ratio of 0.049x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr51.70 Million ≈ $5.56 Million USD) by net assets (Skr1.06 Billion ≈ $114.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can ADDvise Group AB A fund operations to measure how many days the company can operate on defensive assets alone.
ADDvise Group AB A - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how ADDvise Group AB A's cash flow conversion efficiency has evolved over time, based on yearly financial data.
ADDvise Group AB A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ADDvise Group AB A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lasa Supergenerics Limited
NSE:LASA
|
0.005x |
|
ABM International Limited
NSE:ABMINTLLTD
|
0.002x |
|
Gold Basin Resources Corp
V:GXX
|
0.026x |
|
Beston Global Food Company Ltd
AU:BFC
|
-1.028x |
|
Redhill Biopharma Ltd
NASDAQ:RDHL
|
-0.588x |
|
Algorhythm Holdings, Inc.
NASDAQ:RIME
|
10.930x |
|
Indo Komoditi Korpora Tbk PT
JK:INCF
|
0.024x |
|
Zelira Therapeutics Ltd
AU:ZLD
|
0.530x |
Annual Cash Flow Conversion Efficiency for ADDvise Group AB A (2007–2025)
The table below shows the annual cash flow conversion efficiency of ADDvise Group AB A from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see ADDvise Group AB A market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr1.06 Billion ≈ $114.51 Million |
Skr140.50 Million ≈ $15.12 Million |
0.132x | +78.69% |
| 2024-12-31 | Skr835.00 Million ≈ $89.86 Million |
Skr61.70 Million ≈ $6.64 Million |
0.074x | -74.11% |
| 2023-12-31 | Skr613.20 Million ≈ $65.99 Million |
Skr175.00 Million ≈ $18.83 Million |
0.285x | +28.02% |
| 2022-12-31 | Skr492.87 Million ≈ $53.04 Million |
Skr109.88 Million ≈ $11.82 Million |
0.223x | +441.19% |
| 2021-12-31 | Skr247.28 Million ≈ $26.61 Million |
Skr10.19 Million ≈ $1.10 Million |
0.041x | -93.47% |
| 2020-12-31 | Skr91.05 Million ≈ $9.80 Million |
Skr57.44 Million ≈ $6.18 Million |
0.631x | +374.49% |
| 2019-12-31 | Skr84.14 Million ≈ $9.06 Million |
Skr11.19 Million ≈ $1.20 Million |
0.133x | +11291.93% |
| 2018-12-31 | Skr51.41 Million ≈ $5.53 Million |
Skr60.00K ≈ $6.46K |
0.001x | +100.31% |
| 2017-12-31 | Skr49.01 Million ≈ $5.27 Million |
Skr-18.74 Million ≈ $-2.02 Million |
-0.382x | +47.19% |
| 2016-12-31 | Skr46.04 Million ≈ $4.96 Million |
Skr-33.34 Million ≈ $-3.59 Million |
-0.724x | +18.40% |
| 2015-12-31 | Skr4.25 Million ≈ $457.58K |
Skr-3.77 Million ≈ $-406.04K |
-0.887x | -53.54% |
| 2014-12-31 | Skr14.88 Million ≈ $1.60 Million |
Skr-8.60 Million ≈ $-925.39K |
-0.578x | -3.43% |
| 2013-12-31 | Skr11.07 Million ≈ $1.19 Million |
Skr-6.19 Million ≈ $-665.93K |
-0.559x | -172.72% |
| 2012-12-31 | Skr9.65 Million ≈ $1.04 Million |
Skr7.41 Million ≈ $797.76K |
0.768x | +529.10% |
| 2011-12-31 | Skr9.24 Million ≈ $994.69K |
Skr1.13 Million ≈ $121.50K |
0.122x | +120.24% |
| 2010-12-31 | Skr4.30 Million ≈ $463.29K |
Skr-2.60 Million ≈ $-279.59K |
-0.603x | -556.84% |
| 2008-12-31 | Skr2.32 Million ≈ $250.10K |
Skr307.00K ≈ $33.04K |
0.132x | -69.16% |
| 2007-12-31 | Skr3.30 Million ≈ $354.70K |
Skr1.41 Million ≈ $151.95K |
0.428x | -- |
About ADDvise Group AB A
ADDvise Group AB (publ) supplies medical devices, equipment, and consumables to public and private laboratories and research facilities, healthcare, and pharmaceuticals in North America, Europe, South America, Sweden, and internationally. The company provides laboratory furniture, protective ventilation systems, climate-controlled clean rooms, and laboratory equipment; and develops and supplies m… Read more